Stifel Reiterates Buy Rating on Nurix (NRIX)
Tweet Send to a Friend
Stifel analyst Stephen Willey reiterated a Buy rating and $35.00 price target on Nurix (NASDAQ: NRIX).The analyst comments "We expect ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


